MOXIFLOXACIN
Generic: MOXIFLOXACIN
Aurobindo Pharma LimitedManufacturer
OPHTHALMICRoute
MOXIFLOXACIN HYDROCHLORIDEActive Substance
2017-10-04Original Approval
MOXIFLOXACIN is FDA application ANDA206242, sponsored by EUGIA PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class III2018-07-26
Moxifloxacin Ophthalmic Solution USP, 0.5%, 5 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals Inc. BaltimorFailed Impurities/Degradation Specifications: An out-of-specification result in the related substanc
Class III2019-02-26
Moxifloxacin Ophthalmic Solution USP, 0.5%, 3 mL bottle, Rx only, Manufactured by: Lupin Limited, Pithampur (M.P.) 454 7Failed Impurities/Degradation Specifications: Expansion of July 2018 and February 2019 recall due to
Class III2019-12-02
Moxifloxacin Ophthalmic Solution USP, 0.5%, Sterile, 3mL Bottle, Rx Only, For Topical Ophthalmic Use Only, Distributed bDiscoloration: Market complaints of discoloration in Moxifloxacin Ophthalmic Solution.
Class II2022-01-14
Moxifloxacin Ophthalmic Solution, USP 0.5% w/v, 3 mL bottle, Sterile, Rx Only, Distributed by: Aurobindo Pharma USA, IncFailed Impurities/Degradation Specifications
Class III2019-02-01
Moxifloxacin Ophthalmic Solution USP, 0.5%, 3 mL dropper bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Failed Impurities/Degradation Specifications: Out of specification test results in related substance
Top Reported Reactions
1
OFF LABEL USE
2,291 reports
2
DYSPNOEA
2,218 reports
3
ASTHMA
2,143 reports
4
DRUG HYPERSENSITIVITY
2,083 reports
5
DRUG INEFFECTIVE
2,046 reports
6
PNEUMONIA
2,034 reports
7
VOMITING
1,882 reports
8
WHEEZING
1,727 reports
9
PAIN
1,701 reports
10
RASH
1,548 reports